A Directly Negative Interaction of Mir-203 and ZEB2 Modulates Tumor Stemness and Chemotherapy Resistance in Nasopharyngeal Carcinoma

Qingping Jiang,Ying Zhou,Huiling Yang,Libo Li,Xiaojie Deng,Chao Cheng,Yingying Xie,Xiaojun Luo,Weiyi Fang,Zhen Liu
DOI: https://doi.org/10.18632/oncotarget.11691
2016-01-01
Oncotarget
Abstract:miR-203 is a tumor suppressor that is disregulated in numerous malignancies including nasopharyngeal carcinoma (NPC). However, the role of miR-203 in suppressing tumor stemness, chemotherapy resistance as well as its molecular mechanisms are unclear. In this study, we observed that miR-203 suppressed cell migration, invasion, tumor stemness, and chemotherapy resistance to cisplatin (DDP) in vitro and in vivo. miR-203 exerted these effects by targeting ZEB2 and downstream epithelial-mesenchymal transition (EMT) and tumor stemness signals. Interestingly we observed that miR-203 expression was directly suppressed by ZEB2 via targeting its promoter, which significantly reduced cell migration, invasion, tumor stemness, and chemotherapy resistance in NPC cells. Finally, we found that miR-203 was negatively correlated with ZEB2 expression in NPC tissues and tumor spheres. Our data demonstrate a directly negative feedback loop between miR-203 and ZEB2 participating in tumor stemness and chemotherapy resistance, highlighting the therapeutic potential of targeting this signal for NPC chemotherapy.
What problem does this paper attempt to address?